Study guide
16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation
Key Takeaways Explain This Topic AI
Erythropoietin is produced by renal peritubular interstitial cells in response to hypoxia through HIF; red cells live about 120 days, and reticulocytes are normally about 1% of circulating red cells.
Arterial oxygen content is about 1.34 × hemoglobin × SaO2 + 0.003 × PaO2, so anemia lowers oxygen delivery to an ischemic foot even when PaO2 and saturation are normal.
Primary hemostasis is platelet adhesion (GPIb to von Willebrand factor), activation (ADP, thromboxane A2) and aggregation (GPIIb/IIIa binding fibrinogen); von Willebrand disease is the most common inherited bleeding disorder.
In the cell-based model, tissue factor-factor VIIa initiates coagulation, thrombin amplifies it by activating factors V, VIII and XI and platelets, and tenase and prothrombinase complexes on platelets propagate a thrombin burst; factor XIIIa cross-links fibrin.
Natural anticoagulants (antithrombin, protein C with protein S, tissue factor pathway inhibitor) and fibrinolysis (tPA converts plasminogen to plasmin, opposed by PAI-1) limit clot extension.
Last updated: October 2026
16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation
The physiology outline lists hematology : coagulation, platelets, erythrocytes and leukocytes. This physiology explains anemia in the ischemic foot, perioperative bleeding risk and venous thromboembolism. Disorders are covered in 9.1 and 7.3, and the biochemistry of heme and hemoglobin in 18.4.
Hematopoiesis
Blood formation moves from the yolk sac to the fetal liver and spleen and then to the bone marrow . In adults it is concentrated in the axial skeleton and proximal long bones. Pluripotent stem cells give rise to myeloid progenitors (red cells, granulocytes, monocytes and platelets) and lymphoid progenitors.
Growth factor Main source Action
Erythropoietin (EPO) Renal peritubular interstitial cells , triggered by hypoxia through HIF Red cell production; low in CKD (anemia of CKD, 9.3)
- Thrombopoietin (TPO) Liver Megakaryocyte and platelet production
- G-CSF and GM-CSF Macrophages, endothelium Neutrophil production (therapeutic filgrastim, 12.5)
- IL-3, IL-5, IL-7 T cells, stromal cells Multilineage, eosinophil and lymphoid development
- Erythrocytes
Structure: biconcave, anucleate, with no mitochondria. They rely on glycolysis for ATP and the hexose monophosphate shunt for NADPH (18.4).
Lifespan and turnover: red cells live about 120 days and are removed mainly by splenic macrophages. Reticulocytes (newly released cells) are normally about 1% . A rising reticulocyte count shows that the marrow is responding to blood loss or hemolysis.
Indices: MCV (size), MCH and MCHC (hemoglobin content) and RDW (variability) classify anemia (9.1).
Iron balance: the body holds about 3–4 g of iron and loses only about 1 mg a day (more with menstruation). Absorption is regulated by hepcidin , and transport is by transferrin and storage as ferritin .
Oxygen Content and Delivery C a O 2 = 1.34 × [ Hb ] × S a O 2 + 0.003 × P a O 2 C_aO_2 = 1.34 \times [\text{Hb}] \times S_aO_2 + 0.003 \times P_aO_2 C a O 2 = 1.34 × [ Hb ] × S a O 2 + 0.003 × P a O 2
Worked example. With hemoglobin 15 g/dL, SaO2 0.98 and PaO2 95 mmHg: 1.34 × 15 × 0.98 + 0.003 × 95 ≈ 19.7 + 0.3 = 20.0 mL O 2 /dL 1.34 \times 15 \times 0.98 + 0.003 \times 95 \approx 19.7 + 0.3 = 20.0\ \text{mL O}_2\text{/dL} 1.34 × 15 × 0.98 + 0.003 × 95 ≈ 19.7 + 0.3 = 20.0 mL O 2 /dL
If hemoglobin falls to 9 g/dL with the same saturation and PaO2, oxygen content drops to about 12.1 mL O2/dL, a decrease of roughly 40%. Anemia lowers oxygen delivery (cardiac output × CaO2) even though PaO2 and pulse oximetry stay normal. This matters for healing an ischemic ulcer or a fresh flap.
Leukocytes
Cell Usual share of WBCs Functions and clinical clues
Neutrophils About 50–70% First responders to bacteria; segmented nucleus; band forms rise with a "left shift" in acute infection
Lymphocytes About 20–40% B cells (antibodies), T cells (cell-mediated immunity), NK cells; rise in viral infections and CLL
- Monocytes About 2–8% Become tissue macrophages; important in chronic inflammation and wound repair
- Eosinophils About 1–4% Helminths, allergy, drug reactions (DRESS), adrenal insufficiency
- Basophils Less than 1% Histamine release; increased in CML
Neutropenia (absolute neutrophil count below 500/µL) sharply raises the risk of bacterial and fungal infection and blunts pus formation (9.1). Leukemoid reactions are very high WBC counts with mature cells caused by severe infection, not leukemia.
Platelets and Primary Hemostasis
Platelets are anucleate fragments of megakaryocytes. Normal counts are about 150,000–450,000/µL , and each platelet lives about 7–10 days . About one-third are held in the spleen.
Vascular spasm from endothelin and neural reflexes.
Adhesion: platelet GPIb binds von Willebrand factor (vWF) on exposed subendothelial collagen.
Activation: release of ADP and calcium from dense granules and vWF and fibrinogen from alpha granules, plus synthesis of thromboxane A2 (COX-1). Activation turns on GPIIb/IIIa.
Aggregation: GPIIb/IIIa cross-links platelets through fibrinogen to form the platelet plug.
Drugs at each step: aspirin (COX-1, 11.3), P2Y12 inhibitors such as clopidogrel (ADP receptor, 10.4) and GPIIb/IIIa inhibitors. von Willebrand disease , the most common inherited bleeding disorder, causes mucocutaneous bleeding and prolonged bleeding after procedures; desmopressin releases stored vWF in many patients. Spontaneous bleeding becomes a concern below about 10,000–20,000/µL. A count of about 50,000/µL or higher is a common minimum before surgery.
Secondary Hemostasis: The Coagulation System
Classic laboratory pathways still guide test interpretation: PT measures the extrinsic and common pathways (factor VII, X, V, II, fibrinogen) and aPTT measures the intrinsic and common pathways (XII, XI, IX, VIII) (8.4). In the body, coagulation follows the cell-based model :
Initiation: tissue factor on subendothelial cells binds factor VIIa and activates small amounts of IX and X, producing a little thrombin.
Amplification: this thrombin activates platelets and factors V, VIII and XI .
Propagation: on the activated platelet surface, the tenase complex (IXa-VIIIa) and prothrombinase complex (Xa-Va) produce a thrombin burst .
Fibrin formation: thrombin cleaves fibrinogen to fibrin, and factor XIIIa (a transglutaminase) cross-links it into a stable clot.
Vitamin K is required for gamma-carboxylation of factors II, VII, IX and X and proteins C and S (18.4); warfarin blocks this step (10.4). Calcium and phospholipid surfaces are needed for the complexes to assemble.
Natural Anticoagulants and Fibrinolysis
Regulator Action Deficiency or inhibition
Antithrombin Inactivates thrombin and Xa (accelerated about 1,000-fold by heparin) Thrombosis; heparin resistance
Protein C and protein S Thrombin-thrombomodulin activates protein C, which with protein S inactivates Va and VIIIa Thrombosis; warfarin skin necrosis (7.3)
Tissue factor pathway inhibitor Blocks the TF-VIIa-Xa complex
Fibrinolysis tPA converts plasminogen to plasmin , which degrades fibrin into D-dimer Opposed by PAI-1 and alpha-2-antiplasmin; tranexamic acid blocks plasminogen activation
Factor V Leiden resists activated protein C (7.3), illustrating how loss of a natural brake promotes venous thrombosis after lower extremity immobilization.
Blood Groups and Transfusion
The ABO system has naturally occurring IgM antibodies against absent antigens. Type O red cells are the universal donor cells, and AB plasma is the universal donor plasma. Rh(D) -negative people make anti-D only after exposure. An ABO-incompatible transfusion causes an acute hemolytic reaction (Type II hypersensitivity) with fever, hemoglobinuria, hypotension and DIC.